BerGenBio
BerGenBio is a Norway-based clinical-stage biopharmaceutical company that researches and develops AXL therapeutics for the treatment of cancer and COVID -19.
Business Model:
Revenue: $87.8k
Employees: 11-50
Industries / Tags:
Detailed BerGenBio Information
Geographic Data
Address: Jonas Lies vei 91
City: Bergen
State: other
Zip: 5009
Country: NO
Financial Info
Stage:
post ipo debt
Raised Last:
$10M
Raised Total:$143M
Social
Metrics
5,607,570Website Global Rank
1,469Website Monthly Traffic
Twitter Followers
Description
BerGenBio is a Norway-based clinical-stage biopharmaceutical company that researches and develops AXL therapeutics for the treatment of cancer and COVID -19.
Contact Phone:
+14755961159
Contact Email:
BerGenBio went public on 4/6/2017 on the FRA
Listed Exchange:
FRA
IPO Date:
4/6/2017
IPO Valuation:
$98M
Ticker Symbol:
7BG
IPO Price:
$2.8983383478451206/share
Amount Raised:
$46M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2011 | Seed Round | 2 | $1.3M |
Sarsia Seed Management Birk Venture Sarsia Seed Management Sarsia Seed Management Birk Venture Sarsia Seed Management |
5/2013 | Series B | 1 | $6M |
Investinor Investinor Investinor Investinor |
5/2020 | Post-IPO Equity | $48.8M | 3/2016 | Series D | 2 | $25.3M |
Investinor Meteva AS Investinor Meteva AS Investinor Meteva AS Investinor Meteva AS |
2/2014 | Series C | 2 | $12.5M |
Sarsia Seed Management Investinor Investinor Sarsia Seed Management Investinor Investinor |
1/2012 | Series A | 2 | $8.8M |
Sarsia Seed Management Investinor Investinor Sarsia Seed Management Sarsia Seed Management Investinor Investinor Sarsia Seed Management |
3/2016 | Equity | $25.2M |
Investinor AS |
5/2020 | Private Placement | $48.1M | 1/2020 | Private Placement | $24M | 6/2017 | Grant | $2.9M |
Innovasjon Norge |
10/2022 | Post-IPO Debt | $9.5M | 10/2022 | Post-IPO Debt | 1 | $9.6M |
Meteva AS Meteva AS |
1/2020 | Post-IPO Equity | $23.9M | 4/2018 | Post-IPO Equity | $24.1M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
